Gemcitabine Hydrochloride & Myelosuppression
9.8%
of users reported Myelosuppression
68.3%
also reported Severe reaction
59.3%
are women
Most common medical consequences
Severe reaction
68.3%
Hospitalization
20.6%
Life-threatening condition
11.1%
Have you experienced any negative side effects from this medication?
Gemcitabine Hydrochloride: general information
Most common side effects (30)
Most commonly affected ages
10 - 19 years
3.5%
20 - 29 years
<0.1%
30 - 39 years
<0.1%
40 - 49 years
7.0%
50 - 59 years
20.8%
60 - 69 years
30.8%
70 - 79 years
30.9%
80 - 89 years
7.0%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox